Evidence map›Paper›PMID 27409835›Full record

ArticleOncotarget2016

Deletion of 14-3-3σ sensitizes mice to DMBA/TPA-induced papillomatosis.

Markus Winter, Dmitri Lodygin, Berlinda Verdoodt, Heiko Hermeking

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Functions of the RIP kinase family members in the skin.Cellular and molecular life sciences : CMLS · 2023
    Review
  2. Article
  3. Article
  4. Article
  5. Molecular and cytoskeletal regulations in epidermal development.Seminars in cell & developmental biology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Markus WinterExperimental and Molecular Pathology, Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany.
Dmitri LodyginInstitute of Neuroimmunology and Institute for Multiple Sclerosis Research, University Medical Center Göttingen, Göttingen, Germany.
Berlinda VerdoodtInstitute of Pathology, Ruhr-University Bochum, Bochum, Germany.
Heiko HermekingExperimental and Molecular Pathology, Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany.
German Cancer Research Center · DELudwig-Maximilians-Universität München · DERuhr University Bochum · DEUniversitätsmedizin Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The p53-inducible cell cycle regulator 14-3-3σ exhibits tumor suppressive functions and is highly expressed in differentiating layers of the epidermis and hair follicles. 14-3-3σ/SFN/stratifin is frequently silenced in human epithelial cancers, and experimental down-regulation of 14-3-3σ expression immortalizes primary human keratinocytes. In the repeated-epilation (ER) mouse model, a heterozygous nonsense mutation of 14-3-3σ causes repeated hair-loss, hyper-proliferative epidermis, and spontaneous development of papillomas and squamous cell carcinomas in aging mice. Therefore, loss of 14-3-3σ function might contribute to epithelial tumor development. Here, we generated mice with loxP sites surrounding the single 14-3-3σ exon which allowed Cre-mediated deletion of the gene. 14-3-3σ-deficient mice are viable, but demonstrate a permanently disheveled fur. However, histological analyses of the skin did not reveal obvious defects in the hair follicles or the epidermis. Deletion of 14-3-3σ did not enhance spontaneous epidermal tumor development, whereas it increased the frequency and size of DMBA/TPA-induced papillomas. In conclusion, 14-3-3σ is dispensable for normal epidermal homeostasis but critical for suppression of chemically-induced skin carcinogenesis. In addition, these results suggest that the ER mutation of 14-3-3σ is not equivalent to loss of 14-3-3σ, but may represent a gain-of-function variant, which does not reflect the organismal function of wild-type 14-3-3σ.

Indexed as

14-3-3 Proteins9,10-Dimethyl-1,2-benzanthraceneAnimalsCarcinogenesisCell DifferentiationCell ProliferationCodon, NonsenseDisease Models, AnimalDown-RegulationEpidermal CellsEpidermisExonsFemaleGain of Function MutationGene DeletionHair Follicle14-3-3 Proteins9,10-Dimethyl-1,2-benzanthraceneCodon, NonsenseCre recombinaseIntegrasesSfn protein, mouseTetradecanoylphorbol Acetate14-3-3sigma knock-out mouserepeated epilation/ERskin carcinogenesis

Identifiers

PMID27409835
PMCPMC5216908
OpenAlexW2473541658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.